English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A Comparative Study on the Clinical Efficacy and Safety between Combination Therapy with CDK 4/6 Inhibitor and AI Versus AI Monotherapy in HR+/HER type2Advanced Breast Cancer: Updated Meta-analysis Min Ji Kim, Kyung Kim, MoonKyoung Cho, KieHo Sohn, and In-hwan Baek* College of Pharmacy, Kyungsung University, Busan 48434, Republic of Korea Ulsan University Hospital, Ulsan 682-714, Republic of Korea (Received October 22, 2019 · Revised January 23, 2020 · Accepted February 17, 2020)

korean journal of clinical pharmacy/han'gug imsang yaghag hoeji

A Comparative Study on the Clinical Efficacy and Safety between Combination Therapy with CDK 4/6 Inhibitor and AI Versus AI Monotherapy in HR+/HER type2- Advanced Breast Cancer: Updated Meta-analysis